Early impaired β-cell function in chinese women with polycystic ovary syndrome

International Journal of Clinical and Experimental Pathology

Volumn 5, Issue 8, 2012, Pages 777-786

  Tao, Tao ^a   Li, Shengxian ^a   Zhao, Aimin ^b   Mao, Xiuyin ^a   Liu, Wei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Early phase secretion of insulin; Insulin resistance; Polycystic ovary syndrome

Indexed keywords

DIAGNOSTIC AGENT; INSULIN;

ADOLESCENT; ADULT; ARTICLE; CHINA; CLINICAL CHEMISTRY; CROSS-SECTIONAL STUDY; ETHNOLOGY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; METABOLIC SYNDROME X; METABOLISM; OBESITY; OVARY POLYCYSTIC DISEASE; PANCREAS ISLET BETA CELL; PATHOLOGY; SECRETION (PROCESS);

ADOLESCENT; ADULT; BLOOD GLUCOSE; CHINA; CLINICAL CHEMISTRY TESTS; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN-SECRETING CELLS; METABOLIC SYNDROME X; OBESITY; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

EID: 84870438263     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED and Bartzis MI. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999; 84: 4006-4011.
2. Hu W, Hu WH, Qiao J, Wang LN, Zhao CY. Characteristics of abnormal glucose tolerance in patients with polycystic ovary syndrome. Zhonghua Yi Xue Za Zhi 2009; 89: 2053-2055.
3. Legro RS, Gnatuk CL, Kunselman AR and Dunaif A. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab 2005; 90: 3236-3242.
4. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implication for pathogenesis. Endocr Rev 1997; 18: 774-800.
5. Dunaif A and Finegood DT. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab 1996; 81: 942-947.
6. Ehrmann DA, Sturis J, Byrne M, Karrison T, Rosenfield RL and Polonsky K. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1995; 96: 520-527.
7. Arslanian SA, Lewy VD and Danadian K. Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and ß-cell dysfunction and risk of cardiovascular disease. J Clin Endocrinol Metab 2001; 86: 66-71.
8. Holte J, Bergh T, Berne C, Berglund L and Lithell H. Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J Clin Endocrinol Metab1994; 78: 1052-1058.
9. Morin-Papunen LC, Vauhkonen I, Koivunen RM, Ruokonen A and Tapanainen JS. Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome. Hum Reprod 2000; 15: 1266-1274.
10. Gennarelli G, Rovei V, Novi RF, Holte J, Bongioanni F, Revelli A, Pacini G, Cavallo-Perin P and Massobrio M. Preserved insulin sensitivity and beta-cell activity, but decreased glucose effectiveness in normal-weight women with the polycystic ovary syndrome. Clin Endocrinol Metab 2005; 90: 3381-3386.
11. Torréns JI, Skurnick J, Davidow AL, Korenman SG, Santoro N, Soto-Greene M, Lasser N and Weiss G. Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early perimenopausal women without diabetes: the Study of Women's Health Across the Nation (SWAN). Diabetes Care 2004; 27: 354-361
12. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G and He J. Prevalence of Diabetes among Men and Women in China. N Engl J Med 2010; 362: 1090-1101.
13. Ko GT, Chan JC, Cockram CS and Woo J. Prediction of hypertension, diabetes, dyslipidaemia or albuminuria using simple anthropometric indexes in Hong Kong Chinese. Int J Obes Relat Metab Disord 1999; 23: 1136-1142.
14. Dunaif A, Xia J, Book CB, Schenker E and Tang Z. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle: A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest 1995; 96: 801-810.
15. Muniyappa R, Lee S, Chen H and Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008; 294: E15-E26.
16. World Health Organization Western Pacic Region, International Association for the Study of Obesity and International Obesity Task Force 2000. Steering Committee. Assessment diagnosis. The Asia-Pacic Perspective: Redening Obesity and Its Treatment. 2000, pp: 15-21. Health Communications Australia Pty Limited: Melbourne, Australia.
17. Lane DE. Polycystic ovary syndrome and its differential diagnosis. Obstet Gynecol Surv 2006; 61: 125-135.
18. Adams J, Franks S, Polson DW, Mason HD, Abdulwahid N, Tucker M, Morris DV, Price J and Jacobs HS. Multifollicular ovaries: clinical and endocrine features and response to pusatile gonadotropin releasing hormone. Lancet 1985; 2: 1375-1379.
19. Reynders M, Anckaert E, Schiettecatte J and Smitz J. Evaluation of a new automated electrochemiluminescent sex hormone-binding globulin (SHBG) immunoassay. Clin Chem Lab Med 2005; 43: 86-89.
20. Vermeulen A, Verdonck L and Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84: 3666-3672.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
22. Duncan MH, Singh BM, Wise PH, Carter G and Alaghband-Zadeh J. A simple measure of insulin resistance. Lancet 1995; 346: 120-121.
23. Rosolova H, Mayer O Jr, Simon J and Sefrna F. Detection of risk of insulin resistance in the population. Cas Lek Cesk 1998; 137: 80-83.
24. Seltzer HS, Allen EW, Herron AL Jr and Brennan MT. Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest 1996; 746: 323-335.
25. Drivsholm T, Hansen T, Urhammer SA, Palacios RT, Volund A, Borch-Johnsen K and Pedersen OB. Assessment of insulin insensitivity and beta cell function from an oral glucose tolerance test (Abstract). Diabetologia 1999; 42: 185.
26. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neing JL, Ward WK, Beard JC, Palmer JP and Porte D Jr. Quantication of the relationship between insulin sensitivity and beta-cell function in human subjects: evidence for a hyperbolic function. Diabetes 1993; 42: 1663-1672.
27. Retnakaran R, Shen S, Hanley AJ, Vuksan V, Hamilton JK and Zinman B. Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. Obesity 2008; 16: 1901-1907.
28. Utzschneider KM, Prigeon RL, Tong J, Gerchman F, Carr DB, Zraika S, Udayasankar J, Montgomery B, Mari A and Kahn SE. Within-subject variability of measures of β cell function derived from a 2h OGTT: implications for research studies. Diabetologia 2007; 50: 2516-2525.
29. O'Meara NM, Blackman JD, Ehrmann DA, Barnes RB, Jaspan JB, Rosenfield RL and Polonsky KS. Defects in beta-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1993; 76: 1241-1247.
30. Bergman RN, Finegood DT and Kahn SE. The evolution of β-cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest 2002; 32: 35-45.
31. Utzschneider KM, Prigeon RL, Faulenbach MV, Tong J, Carr DB, Boyko EJ, Leonetti DL, Mc-Neely MJ, Fujimoto WY and Kahn SE. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care 2009; 32: 335-341.
32. Koivunen RM, Juutinen J, Vauhkonen I, Morin-Papunen LC, Ruokonen A and Tapanainen JS. Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with a history of gestational diabetes. J Clin Endocrinol Metab 2001; 86: 2591-2599.
33. Kim JW, Han JE, Kim YS, Won HJ, Yoon TK and Lee WS. High sensitivity C-reactive protein and its relationship with impaired glucose regulation in lean patients with polycystic ovary syndrome. Gynecol Endocrinol 2012; 28: 259-263.
34. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 2007; 87: 1409-1439